Toxins 2014, 6(1), 194-210; doi:10.3390/toxins6010194

Review

Cytotoxic Proteins and Therapeutic Targets in Severe Cutaneous Adverse Reactions

Shih-Chi Su ¹ and Wen-Hung Chung ^1,2,* 

+ Authors' affiliations

Received: 28 November 2013; in revised form: 20 December 2013 / Accepted: 27 December 2013 / Published: 3 January 2014

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Lactobacilli regulate Staphylococcus aureus 161:2-induced pro-inflammatory T-cell responses in vitro

Haileselassie Y, Johansson MA, Zimmer CL, Björkander S, Petursdottir DH, Dicksved J, Petersson M, Persson JO, Fernandez C, Roos S, Holmlund U, Sverremark-Ekström E

Department of Molecular Biosciences, the Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.

PloS one [2013, 8(10):e77893]

Type: Journal Article, Research Support, Non-U.S. Gov't, In Vitro
DOI: 10.1371/journal.pone.0077893 

Exogenous interleukin-10 alleviates allergic inflammation but inhibits local interleukin-10 expression in a mouse allergic rhinitis model.

Research article

Shui-Bin Wang¹³, Yu-Qin Deng¹, Jie Ren¹, Bo-Kui Xiao¹, Zheng Liu^2*† and Ze-Zhang Tao^1*†

• *Corresponding authors: Zheng Liu zhengliuent@hotmail.com - Ze-Zhang Tao zezhangtaoent@163.com
• † Equal contributors

Author Affiliations

For all author emails, please log on.

BMC Immunology 2014, 15:9  doi:10.1186/1471-2172-15-9

Published: 25 February 2014

Twenty-first century mast cell stabilizers

Review

You have free access to this content

1. D F Finn and
2. J J Walsh^*

Article first published online: 15 AUG 2013

DOI: 10.1111/bph.12138

© 2013 The Authors. British Journal of Pharmacology © 2013 The British Pharmacological Society

Issue

British Journal of Pharmacology

Special Issue: Themed Issue: Histamine Pharmacology Update. Guest Editor: Paul L Chazot

Volume 170, Issue 1, pages 23–37, September 2013

Impact of endobronchial allergen provocation on macrophage phenotype in asthmatics

Research article

Carla Winkler¹², Lena Witte¹², Natali Moraw², Conny Faulenbach², Meike Müller², Olaf Holz²³, Frank Schaumann² and Jens M Hohlfeld^123*

• *Corresponding author: Jens M Hohlfeld jens.hohlfeld@item.fraunhofer.de

Author Affiliations

For all author emails, please log on.

BMC Immunology 2014, 15:12  doi:10.1186/1471-2172-15-12

Published: 10 March 2014

Depigmented-polymerised allergoids favour regulatory over effector T cells: enhancement by 1α, 25-dihydroxyvitamin D3

Research article

Zoe L Urry¹, David F Richards¹, Cheryl Black¹, Maria Morales², Jerónimo Carnés²,Catherine M Hawrylowicz^1*† and Douglas S Robinson^3*†

• *Corresponding authors: Catherine M Hawrylowiczcatherine.hawrylowicz@kcl.ac.uk - Douglas S Robinsond.s.robinson@imperial.ac.uk
• † Equal contributors

Author Affiliations

¹Department of Allergy and Asthma, MRC and Asthma UK Centre for Mechanisms of Allergic Asthma, Guy’s Campus, King’s College London, London, UK

²Department of Research and Development, Laboratorios Leti, Tres Cantos, Madrid, Spain

³Leukocyte Biology Section, MRC and Asthma UK Centre for Mechanisms of Allergic Asthma, NHLI, Imperial College London, London, UK

For all author emails, please log on.

BMC Immunology 2014, 15:21  doi:10.1186/1471-2172-15-21

The electronic version of this article is the complete one and can be found online at:http://www.biomedcentral.com/1471-2172/15/21

Received:	30 October 2013
Accepted:	16 May 2014
Published:	29 May 2014

© 2014 Urry et al.; licensee BioMed Central Ltd. 

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

A Long-Term Risk? Prenatal POPs Exposure and Asthma in Young Adults

Environ Health Perspect; DOI:10.1289/ehp.122-A28

Lindsey Konkel is a Worcester, MA–based journalist who reports on science, health, and the environment. She is an editor for Environmental Health News and The Daily Climate.

About This Article open

 PDF Version (598 KB)

“The focus in immunotoxicity studies has often been on immunologic intermediates, such as immune cell counts. This study is unique in that it looks at a long-term clinically relevant outcome,” says Todd Jusko, an environmental epidemiologist at the University of Rochester, who was not involved in the study.lthough previous research has suggested that prenatal exposures to persistent organic pollutants (POPs) may be harmful to a child’s developing immune system,1 few studies have investigated long-term outcomes in this regard. Findings reported in this issue of EHP provide evidence that exposure to certain POPs in the womb may be associated with an increased risk of developing asthma that persists into young adulthood.2

Asthma and respiratory physiology: Putting lung function into perspective

Invited Review Series: Respiratory Disease: Using Lung Function Measurements to Greater Advantage

You have free access to this content

1. Giuseppe Francesco Sferrazza Papa¹,
2. Giulia Michela Pellegrino¹ and
3. Riccardo Pellegrino^2,*

Article first published online: 24 JUL 2014

DOI: 10.1111/resp.12355

© 2014 Asian Pacific Society of Respirology

Issue

Respirology

Volume 19, Issue 7, pages 960–969, October 2014

Additional Information(Show All)

How to CiteAuthor InformationPublication History

1. Watch the Video introducing the Review Series on lung function testing
2. The Authors: Giuseppe Francesco Sferrazza Papa, MD, is a Fellow in Respiratory Medicine with interest in chronic obstructive pulmonary diseases, lung function and imaging techniques. Giulia Michela Pellegrino, MD, is a Fellow in Respiratory Medicine with interest in chronic obstructive pulmonary diseases, lung function and clinical research. Riccardo Pellegrino, MD, is Chief of the Department of Allergology and Respiratory Pathophysiology with interest in chronic obstructive pulmonary diseases, lung and airway mechanics, airway hyperresponsiveness and exercise physiology.
3. Series Editors: Graham L. Hall and Charles G. Irvin
4. 
   

• NIHPA Author Manuscripts
• PMC3706515
• 
  • 
    

Pharmacogenomics J. Author manuscript; available in PMC Aug 1, 2014.

Published in final edited form as:

Pharmacogenomics J. Feb 2014; 14(1): 41–47.

Published online Mar 19, 2013. doi:  10.1038/tpj.2013.5

PMCID: PMC3706515

NIHMSID: NIHMS442409

A genome-wide association study of bronchodilator response in asthmatics

Qing Ling Duan, PhD,1,* Jessica Lasky-Su, ScD,1,* Blanca E. Himes, PhD,1,2 Weiliang Qiu, PhD,1 Augusto A. Litonjua, MD, MPH,1,3 Amy Damask, PhD,5 Ross Lazarus, MB, BS,1 Barbara Klanderman, PhD,1 Charles G. Irvin, PhD,6Stephen P. Peters, MD, PhD,7 John P. Hanrahan, MD, MPH,8 John J. Lima, PharmD,9 Fernando D. Martinez, MD,10David Mauger, PhD,11 Vernon M. Chinchilli, PhD,11 Manuel Soto-Quiros, PhD,12 Lydiana Avila, MD,12 Juan C. Celedón, MD, DrPH,13 Christoph Lange, PhD,4 Scott T. Weiss, MD, MS,1,2,3,4 and Kelan G. Tantisira, MD, MPH1,3

Author information ► Copyright and License information ►

Severe Asthma Study – Rob Oliphant - Asthma Society of Canada

Robert Oliphant is the President and CEO of the Asthma Society of Canada.  Rob is the President of the Global Allergy and Asthma Patient Platform and serves on the Steering Committee of Better Care Faster and the Governing Council of the Health Charities Coalition of Canada and was on the Steering Committee for the National Lung Health Framework. In 2013 he was awarded the Queen’s Diamond Jubilee Medal by the Governor General of Canada in recognition of his contributions to Canada.  From 2008 to 2011, Rob served as Member of Parliament of Canada, representing the riding of Don Valley West in the House of Commons.  Rob received his Bachelor of Commerce from the University of Toronto. He has a Masters of Divinity from the Vancouver School of Theology, at the University of British Columbia, and a Doctorate from the Chicago Theological Seminary at the University of Chicago.

Download the Presentation: Closing Presentation – Rob Oliphant | Severe Asthma Study – Rob Oliphant